Загрузка...
Zonisamide add‐on therapy for focal epilepsy
BACKGROUND: The majority of people with epilepsy have a good prognosis, and their seizures can be well controlled with the use of a single antiepileptic agent, but up to 30% develop refractory epilepsy, especially those with focal seizures. In this review, we summarised the evidence from randomised...
Сохранить в:
| Опубликовано в: : | Cochrane Database Syst Rev |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley & Sons, Ltd
2018
|
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6517010/ https://ncbi.nlm.nih.gov/pubmed/30335200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001416.pub4 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|